CME Group Inc. Reports Fourth-Quarter and Full-Year 2023 Financial Results
- None.
- None.
Insights
The reported financial results by CME Group Inc. indicate a robust fiscal performance, characterized by a significant increase in revenue and operating income. A critical factor contributing to this uptick is the surge in interest rate products, which saw a 36% increase in volumes in the fourth quarter. The rise in Treasury futures average daily volume (ADV) by 46% is particularly noteworthy as Treasury futures are a key barometer for gauging investor sentiment towards monetary policy and economic expectations.
From an investor's perspective, the consistent double-digit adjusted earnings growth over ten consecutive quarters signals a strong and stable company performance. Additionally, the dividend policy, including a substantial annual variable dividend, reflects a shareholder-friendly capital return strategy. The 5% increase in the quarterly dividend also suggests confidence in the company's ongoing financial health and its ability to generate cash flow.
However, it's important to monitor the debt level, which stands at $3.4 billion against the cash reserves of approximately $3.1 billion. The company's leverage and liquidity position should be evaluated in the context of its operating income and the broader economic environment, particularly as interest rates fluctuate.
The record annual average daily volume (ADV) of 24.4 million contracts in 2023 highlights CME Group's solid positioning in the derivatives market. The increase in non-U.S. ADV by 28% suggests an expanding global footprint and diversification of CME's client base. This international expansion is a strategic move that can potentially buffer the company against regional economic downturns and enhance its growth prospects.
The enhanced FICC cross-margining program launched by CME Group is another strategic initiative that could attract more participants by offering capital efficiencies. By allowing market participants to offset positions and reduce the amount of capital required for trading, CME Group is enhancing its value proposition, which could lead to increased trading volumes and customer retention.
The performance of CME Group is a microcosm of the broader financial markets and economic conditions. The significant growth in interest rate products is indicative of a volatile interest rate environment where market participants actively seek to hedge against rate fluctuations. This behavior often correlates with periods of economic uncertainty or transition, such as monetary policy changes by central banks.
Looking ahead, the demand for CME's risk management products may continue to be influenced by the macroeconomic landscape, including inflation rates, employment figures and GDP growth. The company's ability to innovate and introduce new products will be crucial in adapting to the evolving needs of market participants amidst such economic shifts.
- Strongest Year in Company History with Interest Rate Products Driving Record Annual Average Daily Volume and Revenue
The company reported revenue of
Total revenue for full-year 2023 was
"As global investors turned to our deep, liquid markets to manage risk across asset classes, CME Group average daily volume climbed to a record 24.4 million contracts in 2023, generating both record revenue and adjusted earnings," said Terry Duffy, CME Group Chairman and Chief Executive Officer. "In Q4, we delivered our tenth consecutive quarter of double-digit adjusted earnings growth. This strong performance was driven, in large part, by a
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials. |
Fourth-quarter 2023 average daily volume (ADV) was 25.5 million contracts, up
Clearing and transaction fees revenue for fourth-quarter 2023 totaled nearly
As of December 31, 2023, the company had approximately
CME Group will hold a Q&A conference call to discuss fourth-quarter 2023 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at www.cmegroup.com. An archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and
Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in trade processing/post trade services (OSTTRA), our primary business and distribution partners' actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission ("SEC") on February 27, 2023, under the caption "Risk Factors".
CME Group Inc. and Subsidiaries | ||||
Consolidated Balance Sheets | ||||
(in millions) | ||||
December 31, 2023 | December 31, 2022 | |||
ASSETS | ||||
Current Assets: | ||||
Cash and cash equivalents | $ 2,912.0 | $ 2,720.1 | ||
Marketable securities | 111.7 | 96.0 | ||
Accounts receivable, net of allowance | 535.6 | 483.2 | ||
Other current assets (includes | 1,138.4 | 529.8 | ||
Performance bonds and guaranty fund contributions | 90,192.5 | 135,249.2 | ||
Total current assets | 94,890.2 | 139,078.3 | ||
Property, net of accumulated depreciation and amortization | 409.5 | 455.5 | ||
Intangible assets—trading products | 17,175.3 | 17,175.3 | ||
Intangible assets—other, net | 3,050.2 | 3,269.7 | ||
Goodwill | 10,495.3 | 10,482.5 | ||
Other assets (includes | 3,685.6 | 3,714.4 | ||
Total Assets | $ 129,706.1 | $ 174,175.7 | ||
LIABILITIES AND EQUITY | ||||
Current Liabilities: | ||||
Accounts payable | $ 90.6 | $ 121.4 | ||
Short-term debt | — | 16.0 | ||
Other current liabilities | 3,133.8 | 2,300.9 | ||
Performance bonds and guaranty fund contributions | 90,192.5 | 135,249.2 | ||
Total current liabilities | 93,416.9 | 137,687.5 | ||
Long-term debt | 3,425.4 | 3,422.4 | ||
Deferred income tax liabilities, net | 5,327.7 | 5,361.1 | ||
Other liabilities | 798.2 | 826.0 | ||
Total Liabilities | 102,968.2 | 147,297.0 | ||
CME Group Shareholders' Equity | 26,737.9 | 26,878.7 | ||
Total Liabilities and Equity | $ 129,706.1 | $ 174,175.7 | ||
CME Group Inc. and Subsidiaries | ||||||||
Consolidated Statements of Income | ||||||||
(dollars in millions, except per share amounts; shares in thousands) | ||||||||
Quarter Ended December 31, | Year Ended December 31, | |||||||
2023 | 2022 | 2023 | 2022 | |||||
Revenues | ||||||||
Clearing and transaction fees | $ 1,184.5 | $ 981.4 | $ 4,588.5 | $ 4,142.7 | ||||
Market data and information services | 167.2 | 153.2 | 663.7 | 610.9 | ||||
Other | 87.6 | 73.2 | 326.7 | 265.8 | ||||
Total Revenues | 1,439.3 | 1,207.8 | 5,578.9 | 5,019.4 | ||||
Expenses | ||||||||
Compensation and benefits | 212.9 | 193.0 | 828.6 | 753.1 | ||||
Technology | 58.5 | 50.0 | 218.7 | 188.6 | ||||
Professional fees and outside services | 36.1 | 38.5 | 144.4 | 137.4 | ||||
Amortization of purchased intangibles | 55.6 | 56.7 | 226.6 | 227.7 | ||||
Depreciation and amortization | 30.7 | 33.9 | 126.0 | 134.9 | ||||
Licensing and other fee agreements | 80.4 | 72.4 | 322.8 | 320.0 | ||||
Other | 101.9 | 95.0 | 276.1 | 241.8 | ||||
Total Expenses | 576.1 | 539.5 | 2,143.2 | 2,003.5 | ||||
Operating Income | 863.2 | 668.3 | 3,435.7 | 3,015.9 | ||||
Non-Operating Income (Expense) | ||||||||
Investment income | 1,076.9 | 1,152.2 | 5,275.3 | 2,198.4 | ||||
Interest and other borrowing costs | (39.7) | (39.9) | (159.4) | (162.7) | ||||
Equity in net earnings (losses) of unconsolidated | 66.8 | 64.0 | 296.9 | 301.1 | ||||
Other non-operating income (expense) | (961.2) | (1,017.3) | (4,694.9) | (1,862.4) | ||||
Total Non-Operating Income (Expense) | 142.8 | 159.0 | 717.9 | 474.4 | ||||
Income before Income Taxes | 1,006.0 | 827.3 | 4,153.6 | 3,490.3 | ||||
Income tax provision | 191.4 | 189.4 | 927.4 | 799.3 | ||||
Net Income | $ 814.6 | $ 637.9 | $ 3,226.2 | $ 2,691.0 | ||||
Net Income Attributable to Common Shareholders of | $ 804.3 | $ 629.9 | $ 3,185.6 | $ 2,657.2 | ||||
Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 2.24 | $ 1.76 | $ 8.87 | $ 7.41 | ||||
Diluted | 2.24 | 1.75 | 8.86 | 7.40 | ||||
Weighted Average Number of Common Shares: | ||||||||
Basic | 359,197 | 358,885 | 359,023 | 358,713 | ||||
Diluted | 359,693 | 359,190 | 359,500 | 359,181 | ||||
CME Group Inc. and Subsidiaries | ||||||||||
Quarterly Operating Statistics | ||||||||||
4Q 2022 | 1Q 2023 | 2Q 2023 | 3Q 2023 | 4Q 2023 | ||||||
Trading Days | 63 | 62 | 62 | 63 | 63 | |||||
Quarterly Average Daily Volume (ADV)(1) | ||||||||||
CME Group ADV (in thousands) | ||||||||||
Product Line | 4Q 2022 | 1Q 2023 | 2Q 2023 | 3Q 2023 | 4Q 2023 | |||||
Interest rates | 9,832 | 14,490 | 11,273 | 10,967 | 13,348 | |||||
Equity indexes | 7,465 | 7,303 | 6,216 | 6,353 | 6,922 | |||||
Foreign exchange | 1,000 | 969 | 898 | 942 | 1,007 | |||||
Energy | 1,829 | 2,083 | 2,104 | 2,126 | 2,158 | |||||
Agricultural commodities | 1,171 | 1,379 | 1,752 | 1,433 | 1,469 | |||||
Metals | 508 | 649 | 612 | 528 | 609 | |||||
Total | 21,803 | 26,873 | 22,855 | 22,349 | 25,513 | |||||
Venue | ||||||||||
CME Globex | 20,279 | 24,171 | 20,907 | 20,838 | 23,503 | |||||
Open outcry | 746 | 1,623 | 1,124 | 713 | 1,126 | |||||
Privately negotiated | 778 | 1,080 | 825 | 797 | 885 | |||||
Total | 21,803 | 26,873 | 22,855 | 22,349 | 25,513 | |||||
Quarterly Average Rate Per Contract (RPC)(1) | ||||||||||
CME Group RPC | ||||||||||
Product Line | 4Q 2022 | 1Q 2023 | 2Q 2023 | 3Q 2023 | 4Q 2023 | |||||
Interest rates | $ 0.500 | $ 0.495 | $ 0.505 | $ 0.508 | $ 0.488 | |||||
Equity indexes | 0.535 | 0.595 | 0.644 | 0.625 | 0.616 | |||||
Foreign exchange | 0.756 | 0.790 | 0.800 | 0.791 | 0.806 | |||||
Energy | 1.181 | 1.300 | 1.347 | 1.324 | 1.338 | |||||
Agricultural commodities | 1.356 | 1.349 | 1.356 | 1.328 | 1.361 | |||||
Metals | 1.519 | 1.517 | 1.487 | 1.492 | 1.502 | |||||
Average RPC | $ 0.651 | $ 0.664 | $ 0.724 | $ 0.707 | $ 0.682 | |||||
1. ADV and RPC includes futures and options on futures only. |
CME Group Inc. and Subsidiaries | ||||||||
Reconciliation of GAAP to non-GAAP Measures | ||||||||
(dollars in millions, except per share amounts; shares in thousands) | ||||||||
Quarter Ended December 31, | Year Ended December 31, | |||||||
2023 | 2022 | 2023 | 2022 | |||||
Net Income | $ 814.6 | $ 637.9 | $ 3,226.2 | $ 2,691.0 | ||||
Restructuring and severance | 2.7 | 1.0 | 17.6 | 11.2 | ||||
Amortization of purchased intangibles(1) | 69.0 | 69.6 | 280.3 | 276.0 | ||||
Litigation matters or settlements | 8.5 | — | 10.5 | — | ||||
Strategic transaction-related costs | — | (3.7) | (2.2) | (0.3) | ||||
Foreign exchange transaction (gains) losses | 13.0 | 10.5 | 12.9 | (13.1) | ||||
Unrealized and realized (gains) losses on investments | 4.7 | (0.7) | (67.1) | (5.3) | ||||
Debt costs related to refinancing | — | — | — | 7.7 | ||||
Realized and unrealized (gains) losses on assets | 0.9 | — | 1.3 | 0.7 | ||||
Trading floor enhancements | — | — | — | 4.8 | ||||
Income tax effect related to above | (15.5) | (15.4) | (44.1) | (55.5) | ||||
Other income tax items(2) | (33.2) | (1.2) | (34.0) | (17.4) | ||||
Adjusted Net Income | $ 864.7 | $ 698.0 | $ 3,401.4 | $ 2,899.8 | ||||
Adjusted Net Income Attributable to Common | $ 853.8 | $ 689.1 | $ 3,358.6 | $ 2,863.2 | ||||
Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 2.24 | $ 1.76 | $ 8.87 | $ 7.41 | ||||
Diluted | 2.24 | 1.75 | 8.86 | 7.40 | ||||
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group: | ||||||||
Basic | $ 2.38 | $ 1.92 | $ 9.35 | $ 7.98 | ||||
Diluted | 2.37 | 1.92 | 9.34 | 7.97 | ||||
Weighted Average Number of Shares: | ||||||||
Basic common shares | 359,197 | 358,885 | 359,023 | 358,713 | ||||
Diluted common shares | 359,693 | 359,190 | 359,500 | 359,181 | ||||
Preferred shares(3) | 4,584 | 4,584 | 4,584 | 4,584 | ||||
1. Includes | ||||||||
2. Other income tax items include benefits recognized for the settlement of various tax audits and for changes in state and local apportionment factors. | ||||||||
3. Preferred shares have similar rights as common shares without voting rights. |
CME-G
View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-fourth-quarter-and-full-year-2023-financial-results-302061283.html
SOURCE CME Group
FAQ
What was CME Group's revenue in Q4 2023?
What was CME Group's net income in Q4 2023?
What was CME Group's full-year revenue for 2023?
Who is the CEO of CME Group?
What was the total average rate per contract for CME Group in Q4 2023?
